Literature DB >> 7401824

[Nerve sheath tumors: malignant schwannoma (author's transl)].

D Steiner, W Böcker.   

Abstract

The morphology and biology of tumors of the nerve sheath show rather heterogeneous aspects. In most the site of origin seems to be the Schwann's cells. Essentially these tumors can be differentiated into three groups: 1. malignant schwannoma, 2. neurinoma, and 3. neurofibroma. Although the Schwann's cell is the common origin, the three different tumors can be well differentiated histologically with the exception of malignant schwannoma and spindle cell sarcoma. The clinical symptoms are determined by the location of the tumor and are without general characteristics. The treatment of choice is always radical surgery. In addition, radiation and chemotherapy are indicated in special cases.

Entities:  

Mesh:

Year:  1980        PMID: 7401824     DOI: 10.1007/bf01241932

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  9 in total

1.  PRIMARY MALIGNANT NEOPLASMS OF NERVES (MALIGNANT NEURILEMOMAS) IN PATIENTS WITHOUT MANIFESTATIONS OF MULTIPLE NEUROFIBROMATOSIS (VON RECKLINGHAUSEN'S DISEASE).

Authors:  A N D'AGOSTINO; E H SOULE; R H MILLER
Journal:  Cancer       Date:  1963-08       Impact factor: 6.860

2.  Malignant Schwannoma associated with von Recklinghausen's neurofibromatosis.

Authors:  J G Guccion; F M Enzinger
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-07-27

3.  Malignant neurilemmomas of peripheral nerves.

Authors:  J O VIETA; G T PACK
Journal:  Am J Surg       Date:  1951-10       Impact factor: 2.565

Review 4.  Tumors of the peripheral nervous system.

Authors:  M R Abell; W R Hart; J R Olson
Journal:  Hum Pathol       Date:  1970-12       Impact factor: 3.466

5.  Combination therapy of solid tumors using 1,3-bis(2-chloroethyl)-1-nitrosourea (NCNU), vincristine, methotrexate, and 5-fluorouracil.

Authors:  G A Omura; G A Roberts
Journal:  Cancer       Date:  1973-06       Impact factor: 6.860

6.  Malignant schwannoma. A clinicopathologic study.

Authors:  B C Ghosh; L Ghosh; A G Huvos; J G Fortner
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860

7.  Solitary malignant schwannoma.

Authors:  T K Das Gupta; R D Brasfield
Journal:  Ann Surg       Date:  1970-03       Impact factor: 12.969

8.  Survival in malignant schwannoma. An 18-year study.

Authors:  H R White
Journal:  Cancer       Date:  1971-03       Impact factor: 6.860

9.  Combination chemotherapy of metastatic malignant schwannoma with vincristine, adriamycin, cyclophosphamide, and imidazole carboxamide: a case report.

Authors:  R L Goldman; S E Jones; R S Heusinkveld
Journal:  Cancer       Date:  1977-05       Impact factor: 6.860

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.